Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus

Journal of Infectious Diseases

Volumn 181, Issue 5, 2000, Pages 1768-1771

  Hancock, Gerald E ^a   Smith, Jason D ^a   Heers, Kristen M ^a  

^a Wyeth Lederle Vaccines ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; NEUTRALIZING ANTIBODY;

ANIMAL TISSUE; ARTICLE; CHIMPANZEE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VIRUS INFECTIVITY; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; HN PROTEIN; MALE; NEUTRALIZATION TESTS; PAN TROGLODYTES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TIME FACTORS; VACCINES, ATTENUATED; VACCINES, SYNTHETIC; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS; VIRAL PROTEINS;

EID: 0034080129     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315475     Document Type: Article

References (15)

1. 1. Domachowske JB, Rosenberg HF. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev 1999;12:298-309.
2. 2. Han LL, Alexander JP, Anderson, LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999; 179:25-30.
3. 3. Kapikian AZ, Mitchell RH, Chanock RM, Shevdoff RA, Stewart, CE. An epidemiological study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 1968;89:405-13.
4. 4. Falsey AR, Walsh EE. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly. Vaccine 1997;15:1130-2.
5. 5. Falsey AR, Walsh, EE. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60. Vaccine 1996;14:1214-8.
6. 6. Tristram DA, Welliver RC, Mohar CK, Hogerman DA, Hildreth SW, Paradiso P. Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old. J Infect Dis 1993;167: 191-5.
7. 7. Piedra PA, Glezen WP, Kasel JA, et al. Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection. Vaccine 1995;13:1095-101.
8. 8. Groothuis JR, King SJ, Hogerman DA, Paradiso PR, Simoes EA. Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia. J Infect Dis 1998;177:467-9.
9. 9. Hancock GE, Speelman DJ, Heers K, Bortell E, Smith J, Cosco C. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein or respiratory syncytial virus. J Virol 1996;70:7783-91.
10. 10. Hancock GE, Smith JD, Heers KM. The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12. Viral Immunol 2000; 13:57-72.
11. 11. Firestone CY, Whitehead SS, Collins PL, Murphy BR, Crowe JE Jr. Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate. Virology 1996;225:419-22.
12. 12. Crowe JE Jr, Bui PT, Firestone CY, et al. Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. J Infect Dis 1996;173:829-39.
13. 13. Anderson LJ, Bingham P, and Hierholzer JC. Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. J Virol 1988;62:4232-8.
14. 14. Sakurai H, Williamson RA, Crowe JE, et al. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. J Virol 1999;73:2956-62.
15. 15. Walsh EE, Schlesinger JJ, Brandriss MW. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect Immun 1984;43:756-8.